MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+1.42%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$536M
AUM Growth
+$536M
(+60%)
Cap. Flow
+$187M
Cap. Flow
% of AUM
34.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Dyne Therapeutics
DYN
|
$100M |
| 2 |
iTeos Therapeutics
ITOS
|
$91.4M |
Top Sells
| 1 |
Syndax Pharmaceuticals
SNDX
|
$4.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Dyne Therapeutics
DYN
$1.92B
| $100M | 18.64% | +4,951,303 | New | +$100M |
|
2
Repare Therapeutics
RPTX
$71.7M
| $92.4M | 17.24% | 3,003,772 | – | – |
|
|
3
iTeos Therapeutics
ITOS
| $91.4M | 17.05% | +3,706,663 | New | +$91.4M |
|
|
TCRR
4
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $82.3M | 15.35% | 4,050,865 | – | – |
|
|
HARP
5
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $76.9M | 14.33% | 4,524,425 | – | – |
|
6
Rhythm Pharmaceuticals
RYTM
$6.85B
| $41.4M | 7.72% | 1,909,258 | – | – |
|
|
7
Syndax Pharmaceuticals
SNDX
$1.41B
| $27.2M | 5.07% | 1,843,388 -325,303 | -15% | -$4.8M |
|
|
CHMA
8
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $24.7M | 4.6% | 5,736,296 | – | – |
|